Webinar: Impact of COVID-19 on Patient Support Programs in Canada
By Innomar Strategies
Alison Drinkwater, Senior Director, InnomarConsulting and Rod Tarajos, Senior Director Business Intelligence at Innomar Strategies review of key insights and the impacts of COVID-19 on Patient Support Programs across Canada.
Topics to be Explored:
- Focused insights on four key therapeutics areas in Patient Support Programs; Immunology, Oncology and Rare Diseases
- Data during the COVID-19 pandemic from March to August 2020 exploring impact and thoughts around;
- Patient enrolments and access to treatment and support
- Key insights in Reimbursement access
- Continuation of Therapy
- Overview and Insights into the Reimbursement landscape- trends with both the Public and Private Payers during COVID-19
- Facilitated panel session with key opinion leaders on their experiences and insights with COVID-19. Panelists are:
- Joan Heatherington, Acute care nurse practitioner, University of Calgary's Inflammatory Bowel Disease Clinic
- Dr. Sterrett, Rheumatologist
- Dr. Narula, Associate Professor of Medicine, Division of Gastroenterology, McMaster University Hamilton Health Sciences
- Josephine Cavarra, Regional Director for Ontario, Crohn’s and Colitis Canada
- Sarah Trebinskie, Reimbursement Coordinator, The Ottawa Hospital Cancer Centre
Topics:
Regulatory
